YY003

· Chongqing Claruvis Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for YY003, covering 2025-03-21 to 2025-03-21. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Investigate the Safety and Efficacy of YY003 in Adults with Moderate to Severe Glabellar Lines [Phase 2]

See pricing